Search results for "non-steroid"

showing 10 items of 287 documents

Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis

2017

Objectives:\ud \ud To investigate whether low-dose aspirin (<300 mg/d) can influence the onset of cognitive impairment or dementia in observational studies and improve cognitive test scores in randomized controlled trials (RCTs) in participants without dementia.\ud \ud Design:\ud \ud Systematic review and meta-analysis.\ud \ud Setting:\ud \ud Observational and interventional studies.\ud \ud Participants:\ud \ud Individuals with no dementia or cognitive impairment initially.\ud \ud Measurements:\ud \ud Odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for the maximum number of covariates from each study, were used to summarize data on the incidence of dementia and cognitive impa…

Gerontologymedicine.medical_specialtyaspirinArticlelaw.invention03 medical and health sciencesCognition0302 clinical medicineRandomized controlled triallawaspirin; cognitive impairment; dementia; meta-analysis; Geriatrics and GerontologyInternal medicinemedicineHumansDementia030212 general & internal medicineCognitive declineRandomized Controlled Trials as Topiccognitive impairmentbusiness.industryAnti-Inflammatory Agents Non-SteroidalCognitionOdds ratiomedicine.diseaseCognitive testmeta-analysisMeta-analysisDementiaObservational studyGeriatrics and GerontologyCognition Disordersbusiness030217 neurology & neurosurgery
researchProduct

Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review

2022

Abstract Background Several studies have reported that glucosamine sulfate (GS) can improve knee osteoarthritis (OA) symptomatology. In parallel, the disease-modifying effects of non-steroidal anti-inflammatory drugs (NSAIDs) in knee OA have also been investigated. However, limited literature has reported the combined effect of GS and NSAIDs. The aim of this scoping review is to describe the scope and volume of the literature investigating the potential benefits and synergistic effect of a combination of GS and NSAIDs in patients with knee OA. Methods PubMed and Embase were searched for studies published from inception through April 2022, evaluating the effects of the combination of GS and …

GlucosamineObservational Studies as TopicRheumatologyCelecoxibAnti-Inflammatory Agents Non-SteroidalHumansPainOrthopedics and Sports MedicineCelecoxib Chondroprotective effect Cyclooxygenase 2 inhibitors Glucosamine sulfate Non-steroidal anti-inflammatory drugs OsteoarthritisSynergistic effectsOsteoarthritis KneeRandomized Controlled Trials as Topic
researchProduct

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

1991

Leflunomide has been shown to be very effective in preventing and curing several autoimmune animal diseases. Further, this agent is as effective as cyclosporin A in preventing the rejection of skin and kidney transplants in rats. Preliminary results from patients suffering from severe cases of rheumatoid arthritis demonstrated that clinical and immunological parameters could be improved with leflunomide therapy. Mode of action studies revealed that this substance antagonizes the proliferation inducing activity of several cytokines and is cytostatic for certain cell types. In this light, we could show that tyrosine phosphorylation of the RR-SRC peptide substrate and the autophosphorylation o…

Graft RejectionImmunologyMolecular Sequence DataGraft vs Host DiseasePharmacologyToxicologyAutoimmune Diseaseschemistry.chemical_compoundEpidermal growth factorCyclosporin amedicineAnimalsHumansPharmacology (medical)Amino Acid SequenceMode of actionLeflunomidePharmacologybusiness.industryAnti-Inflammatory Agents Non-SteroidalTyrosine phosphorylationIsoxazolesmedicine.diseaseTransplantationDisease Models AnimalchemistryRheumatoid arthritisImmunologybusinessTyrosine kinaseImmunosuppressive AgentsLeflunomidemedicine.drugAgents and actions
researchProduct

Effects of leflunomide on immune responses and models of inflammation.

1993

Leflunomide is an antiphlogistic and immunomodulating agent that has been shown to be effective in preventing and healing autoimmune disorders and reactions leading to organ graft rejection. From our preliminary clinical data [4], we now have hopes that these effects, observed in experimental animals, can truly be transferred to humans. Although we are far from understanding the mode of action of leflunomide, we are slowly gathering some insight. A good many of the immunosuppressive effects of leflunomide can be attributed to the antagonistic effects it has on responses to many cytokines, most likely through receptor expression and signal transduction (tyrosine kinase inhibition). The inhib…

Graft RejectionReceptor expressionImmunologyDrug Evaluation PreclinicalAutoimmune Diseaseschemistry.chemical_compoundMiceImmune systemMedicineAnimalsHumansLeflunomideInflammationImmunity Cellularbusiness.industryAnti-Inflammatory Agents Non-SteroidalAutoantibodyGeneral MedicineIsoxazolesProtein-Tyrosine KinasesRatsDisease Models AnimalchemistryImmunologyAntibody FormationCytokinesSignal transductionbusinessTyrosine kinaseImmunomodulating AgentHistamineImmunosuppressive AgentsLeflunomidemedicine.drugSpringer seminars in immunopathology
researchProduct

Histopathologic study on the effect of Tenoxicam and its diluent in the venous endothelium, in rabbits

2000

Made available in DSpace on 2021-07-14T10:23:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2000-06 Com o objetivo de avaliar pela histopatologia o efeito do tenoxicam e do seu diluente no endotélio venoso, foram utilizados 48 coelhos (Oryctolagus cuniculus), rancos, da linhagem Nova Zelândia, machos, com idade acima de 10 semanas, com peso variando entre 2350 e 3500 gramas, divididos em dois grupos, denominados Experimento e Controle, que foram observados nos tempos de 6, 12 e 24 horas. Administrou-se nas venae auriculares dextra e sinistra, diluente ou tenoxicam/diluente no Grupo Experimento e cloreto de sódio a 0,9% no Grupo Controle. Não se observou diferença estatisticamente sign…

GynecologyPhysicsmedicine.medical_specialtyAntiinflamatórios não esteróideslcsh:Surgerylcsh:RD1-811EndotélioPatologiaCoelhosAnti-inflamatory agents non-steroidalmedicinePathologySurgeryEndotheliumRabbits
researchProduct

Constituents of leaves and flowers essential oils of Helichrysum pallasii (Spreng.) Ledeb. growing wild in Lebanon.

2009

The chemical compositions of the essential oils obtained from leaves and flowers of Helichrysum pallasii were analyzed by gas chromatography and gas chromatography-mass spectrometry. Among the 102 identified constituents, hexadecanoic acid (16.2%), (Z,Z)-9,12-octadecadienoic acid (6.8%), tetradecanoic acid (2.6%), and (Z)-caryophyllene (4.2%) were the main constituent of the oil from leaves, while in the oil from flowers hexadecanoic acid (14.7%), (Z,Z)-9,12-octadecadienoic acid (14.2%), (Z)-caryophyllene (3.6%), and delta-cadinene (3.1%) predominated. The oils were both characterized by sesquiterpenes (33.4% for leaves and 33.7% for flowers, respectively) and fatty acids and esters (30.3% …

Helichrysum pallasii (Spreng.) Ledeb.Palmitic AcidMedicine (miscellaneous)Myristic acidFlowersMyristic Acidlaw.inventionPalmitic acidMinimum inhibitory concentrationchemistry.chemical_compoundlawBotanyOils VolatileStaphylococcus epidermidisPlant OilsFood scienceLebanonEssential oilHelichrysumPolycyclic SesquiterpenesNutrition and DieteticsbiologyBacteriaPlant ExtractsAnti-Inflammatory Agents Non-SteroidalFatty AcidsEstersAsteraceaebiology.organism_classificationAnti-Bacterial AgentsPlant LeaveschemistryHelichrysumFatty Acids UnsaturatedStearic acidGas chromatographySesquiterpenesJournal of medicinal food
researchProduct

HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY

2011

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) characterized by damage of large bowel mucosa and frequent extra-intestinal autoimmune comorbidities. The role played in IBD pathogenesis by molecular chaperones known to interact with components of the immune system involved in inflammation is unclear. We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis. In the present work we investigated three other heat shock protein/molecular chaperones:…

HistologyBiophysicsDown-RegulationInflammationcomorbidity.Inflammatory bowel diseaseulcerative colitis heat shock proteins Hsp molecular chaperones inflammation comorbidity.Pathogenesischemistry.chemical_compoundMesalazineulcerative colitis heat shock proteins Hsp molecular chaperones inflammation comorbidityHeat shock proteinChaperonin 10MedicineHspHumansHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsColitisMesalaminelcsh:QH301-705.5ulcerative colitisbusiness.industryBrief Reportmolecular chaperonesAnti-Inflammatory Agents Non-SteroidalCell Biologymedicine.diseaseUlcerative colitisImmunohistochemistrydigestive system diseaseschemistrylcsh:Biology (General)inflammationImmunologyheat shock proteinsBiomarker (medicine)Colitis Ulcerativemedicine.symptombusiness
researchProduct

Development of an lbuprofen-Releasing Biodegradable PLA/PGA Electrospun Scaffold for Tissue Regeneration

2009

Our aim was to develop a biodegradable fibrous dressing to act as a tissue guide for in situ wound repair while releasing Ibuprofen to reduce inflammation in wounds and reduce pain for patients on dressing changes. Dissolving the acid form of Ibuprofen (from 1% to 10% by weight) in the same solvent as 75% polylactide, 25% polyglycolide (PLGA) polymers gave uniformly loaded electrospun fibers which gave rapid release of drug within the first 8 h and then slower release over several days. Scaffolds with 10% Ibuprofen degraded within 6 days. The Ibuprofen released from these scaffolds significantly reduced the response of fibroblasts to major pro-inflammatory stimulators. Fibroblast attachment…

KeratinocytesScaffoldPolyglycolidePolyesterswound healingBioengineeringBiocompatible MaterialsIbuprofenbiodegradationApplied Microbiology and Biotechnologychemistry.chemical_compoundTissue engineeringmedicineCell AdhesionHumansdrug releaseCells CulturedCell ProliferationTissue EngineeringTissue ScaffoldsChemistryorganic chemicalsRegeneration (biology)Anti-Inflammatory Agents Non-SteroidalFibroblastsIbuprofenPLGAinflammationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsLiberationWound healingPolyglycolic AcidBiotechnologyBiomedical engineeringmedicine.drug
researchProduct

New acetophenone glucosides isolated from extracts of Helichrysum italicum with antiinflammatory activity.

2001

Three new acetophenone glucosides (4-6), three known aglycons (1-3), and a benzo-gamma-pyrone glucoside (7) were isolated from the CH(2)Cl(2), EtOAc, and BuOH extracts from the aerial parts of Helichrysum italicum. All the compounds tested showed antiinflammatory activity in a 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced mouse ear edema test, and the ID(50) value of compound 2, the most active compound, was determined.

KetoneMagnetic Resonance SpectroscopySpectrophotometry InfraredStereochemistryIndomethacinPharmaceutical SciencePharmacognosyAsteraceaeHelichrysum italicumAnalytical Chemistrychemistry.chemical_compoundMiceGlucosideGlucosidesPhenolsDrug DiscoverySpectroscopy Fourier Transform InfraredAnimalsEdemaBenzopyransPharmacologychemistry.chemical_classificationPlants MedicinalbiologyDose-Response Relationship DrugPlant Extractsbeta-GlucosidaseOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalGlycosideAcetophenonesbiology.organism_classificationComplementary and alternative medicinechemistryAldoseActive compoundSpainMolecular MedicineTetradecanoylphorbol AcetateSpectrophotometry UltravioletChromatography Thin LayerAcetophenoneJournal of natural products
researchProduct

Determination of non-steroidal anti-inflammatory drugs in water and urine using selective molecular imprinted polymer extraction and liquid chromatog…

2016

Abstract A selective solid-phase extraction was employed for the improvement of the determination of non-steroidal anti-inflammatory drugs (NSAIDs) in continental water and urine samples. Ketoprofen, naproxen, diclofenac, and ibuprofen were selected as target analytes due to they are the most frequently administered and consumed NSAIDs. These compounds were extracted using molecular imprinted polymers and determined by liquid chromatography with diode array (DAD), and tandem-mass spectrometry (MS–MS) detectors. Performance of DAD and MS–MS detectors was evaluated throughout this study. The obtained limits of quantification, after a 50-fold preconcentration solid-phase extraction, varied fro…

KetoprofenAnalyteNaproxenPolymersClinical BiochemistryPharmaceutical Science02 engineering and technologyUrineMass spectrometry01 natural sciencesAnalytical ChemistryMolecular ImprintingTandem Mass SpectrometryDrug DiscoverymedicineSpectroscopyChromatographyChemistryAnti-Inflammatory Agents Non-Steroidal010401 analytical chemistryExtraction (chemistry)Molecularly imprinted polymerWater021001 nanoscience & nanotechnologyIbuprofen0104 chemical sciences0210 nano-technologyWater Pollutants ChemicalChromatography Liquidmedicine.drugJournal of Pharmaceutical and Biomedical Analysis
researchProduct